Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: hCG|BRCA1 Mutation|BRCA2 Mutation
Interventions: DRUG: Ovitrelle
Sponsor: University Hospital, Ghent
Collaborators: Fox Chase Cancer Center|Ziekenhuis Oost-Limburg